Auricle, Inc.

Commercializes the Susan Shore Device (SSD), a bimodal auditory-somatosensory stimulation device for somatic tinnitus. Licensee of intellectual property developed in Dr. Susan Shore's lab at the University of Michigan, co-founded by Shore and David Martel, PhD. Has not disclosed an FDA submission or approval timeline. As of September 2026, CEO Jon Pearson has departed and David Martel (VP of R&D) also left, a fundraising round did not succeed, and the original lead investor is weighing whether to restructure the company under a new CEO or return the licensed IP to the University of Michigan (source: Tinnitus Quest).